National Research Corp (NRC) is not a strong buy at the moment due to weak financial performance, lack of positive news catalysts, and a neutral technical setup. While insider buying is a positive signal, the company's declining revenue, net income, and EPS suggest caution for a long-term beginner investor. Given the user's impatience and preference for long-term investments, holding off on this stock is advisable until there are clearer signs of growth or positive momentum.
The technical indicators are mixed. The MACD is slightly positive but contracting, RSI is neutral at 52.836, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock closed below the pivot point (17.214), with key support at 16.714 and resistance at 17.714. The short-term trend suggests a potential decline of -2.8% in the next week.

Insider buying has increased significantly by 881.62% over the last month, indicating confidence from company insiders.
The company's financial performance in 2025/Q4 showed a significant decline in revenue (-4.64% YoY), net income (-77.29% YoY), EPS (-75.00% YoY), and gross margin (-4.74% YoY). No recent news or events to drive positive sentiment.
In 2025/Q4, revenue dropped to $35.19M (-4.64% YoY), net income fell to $1.49M (-77.29% YoY), EPS declined to $0.07 (-75.00% YoY), and gross margin decreased to 54.31% (-4.74% YoY). These metrics indicate a weak financial quarter with declining profitability and growth.
No recent analyst ratings or price target changes available for NRC.
